Works matching AU Yuan, Xiaoyong


Results: 63
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan‐L‐CN randomized controlled trial

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2182, doi. 10.1111/dom.14803
    By:
    • Yuan, Xiaoyong;
    • Guo, Xiaohui;
    • Zhang, Junqing;
    • Dong, Xiaolin;
    • Lu, Yibing;
    • Pang, Wuyan;
    • Gu, Shenghong;
    • Niemoeller, Elisabeth;
    • Ping, Lin;
    • Nian, Gaowei;
    • Souhami, Elisabeth
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50